116 related articles for article (PubMed ID: 22080632)
1. C1-esterase inhibitor infusion increases survival rates for patients with sepsis*.
Igonin AA; Protsenko DN; Galstyan GM; Vlasenko AV; Khachatryan NN; Nekhaev IV; Shlyapnikov SA; Lazareva NB; Herscu P
Crit Care Med; 2012 Mar; 40(3):770-7. PubMed ID: 22080632
[TBL] [Abstract][Full Text] [Related]
2. Phase 2 trial of eritoran tetrasodium (E5564), a toll-like receptor 4 antagonist, in patients with severe sepsis.
Tidswell M; Tillis W; Larosa SP; Lynn M; Wittek AE; Kao R; Wheeler J; Gogate J; Opal SM;
Crit Care Med; 2010 Jan; 38(1):72-83. PubMed ID: 19661804
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks.
Craig TJ; Levy RJ; Wasserman RL; Bewtra AK; Hurewitz D; Obtułowicz K; Reshef A; Ritchie B; Moldovan D; Shirov T; Grivcheva-Panovska V; Kiessling PC; Keinecke HO; Bernstein JA
J Allergy Clin Immunol; 2009 Oct; 124(4):801-8. PubMed ID: 19767078
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis.
Rice TW; Wheeler AP; Bernard GR; Vincent JL; Angus DC; Aikawa N; Demeyer I; Sainati S; Amlot N; Cao C; Ii M; Matsuda H; Mouri K; Cohen J
Crit Care Med; 2010 Aug; 38(8):1685-94. PubMed ID: 20562702
[TBL] [Abstract][Full Text] [Related]
5. Is continuous infusion ceftriaxone better than once-a-day dosing in intensive care? A randomized controlled pilot study.
Roberts JA; Boots R; Rickard CM; Thomas P; Quinn J; Roberts DM; Richards B; Lipman J
J Antimicrob Chemother; 2007 Feb; 59(2):285-91. PubMed ID: 17135183
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience with polyclonal IgM-enriched immunoglobulins in a group of patients affected by sepsis after cardiac surgery.
Buda S; Riefolo A; Biscione R; Goretti E; Cattabriga I; Grillone G; Bacchi-Reggiani L; Pacini D
J Cardiothorac Vasc Anesth; 2005 Aug; 19(4):440-5. PubMed ID: 16085247
[TBL] [Abstract][Full Text] [Related]
7. C1-inhibitor autoantibodies in SLE.
Mészáros T; Füst G; Farkas H; Jakab L; Temesszentandrási G; Nagy G; Kiss E; Gergely P; Zeher M; Griger Z; Czirják L; Hóbor R; Haris A; Polner K; Varga L
Lupus; 2010 Apr; 19(5):634-8. PubMed ID: 20071476
[TBL] [Abstract][Full Text] [Related]
8. Acetyl salicylic acid usage and mortality in critically ill patients with the systemic inflammatory response syndrome and sepsis.
Eisen DP; Reid D; McBryde ES
Crit Care Med; 2012 Jun; 40(6):1761-7. PubMed ID: 22610182
[TBL] [Abstract][Full Text] [Related]
9. C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks--final results of the I.M.P.A.C.T.2 study.
Craig TJ; Bewtra AK; Bahna SL; Hurewitz D; Schneider LC; Levy RJ; Moy JN; Offenberger J; Jacobson KW; Yang WH; Eidelman F; Janss G; Packer FR; Rojavin MA; Machnig T; Keinecke HO; Wasserman RL
Allergy; 2011 Dec; 66(12):1604-11. PubMed ID: 21884533
[TBL] [Abstract][Full Text] [Related]
10. Administration of C1-esterase inhibitor during emergency coronary artery bypass surgery in acute ST-elevation myocardial infarction.
Thielmann M; Marggraf G; Neuhäuser M; Forkel J; Herold U; Kamler M; Massoudy P; Jakob H
Eur J Cardiothorac Surg; 2006 Aug; 30(2):285-93. PubMed ID: 16829095
[TBL] [Abstract][Full Text] [Related]
11. Serum concentrations of C reactive protein, alpha1 antitrypsin, and complement (C3, C4, C1 esterase inhibitor) before and during the Vuelta a Espańa.
Semple SJ; Smith LL; McKune AJ; Hoyos J; Mokgethwa B; San Juan AF; Lucia A; Wadee AA
Br J Sports Med; 2006 Feb; 40(2):124-7. PubMed ID: 16431998
[TBL] [Abstract][Full Text] [Related]
12. Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration?
Roberts JA; Roberts MS; Robertson TA; Dalley AJ; Lipman J
Crit Care Med; 2009 Mar; 37(3):926-33. PubMed ID: 19237898
[TBL] [Abstract][Full Text] [Related]
13. C1-esterase-inhibitor for primary graft dysfunction in lung transplantation.
Sommer W; Tudorache I; Kühn C; Avsar M; Salman J; Ius F; Gras C; Weber P; Welte T; Gottlieb J; Haverich A; Warnecke G
Transplantation; 2014 Jun; 97(11):1185-91. PubMed ID: 24573112
[TBL] [Abstract][Full Text] [Related]
14. Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement.
Nielsen EW; Waage C; Fure H; Brekke OL; Sfyroera G; Lambris JD; Mollnes TE
Mol Immunol; 2007 Mar; 44(8):1819-26. PubMed ID: 17101176
[TBL] [Abstract][Full Text] [Related]
15. C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naïve patients.
Varga L; Széplaki G; Visy B; Füst G; Harmat G; Miklós K; Németh J; Cervenak L; Karádi I; Farkas H
Mol Immunol; 2007 Feb; 44(6):1454-60. PubMed ID: 16750855
[TBL] [Abstract][Full Text] [Related]
16. Administration of human protein C improves survival in an experimental model of sepsis.
Messaris E; Betrosian AP; Memos N; Chatzigianni E; Boutsikou M; Economou V; Dontas I; Theodossiades G; Konstadoulakis MM; Douzinas EE
Crit Care Med; 2010 Jan; 38(1):209-16. PubMed ID: 19726977
[TBL] [Abstract][Full Text] [Related]
17. Effects of nitroglycerin on sublingual microcirculatory blood flow in patients with severe sepsis/septic shock after a strict resuscitation protocol: a double-blind randomized placebo controlled trial.
Boerma EC; Koopmans M; Konijn A; Kaiferova K; Bakker AJ; van Roon EN; Buter H; Bruins N; Egbers PH; Gerritsen RT; Koetsier PM; Kingma WP; Kuiper MA; Ince C
Crit Care Med; 2010 Jan; 38(1):93-100. PubMed ID: 19730258
[TBL] [Abstract][Full Text] [Related]
18. Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators.
Orfanos SE; Kotanidou A; Glynos C; Athanasiou C; Tsigkos S; Dimopoulou I; Sotiropoulou C; Zakynthinos S; Armaganidis A; Papapetropoulos A; Roussos C
Crit Care Med; 2007 Jan; 35(1):199-206. PubMed ID: 17110873
[TBL] [Abstract][Full Text] [Related]
19. C1 esterase inhibitor activity in amniotic fluid embolism.
Tamura N; Kimura S; Farhana M; Uchida T; Suzuki K; Sugihara K; Itoh H; Ikeda T; Kanayama N
Crit Care Med; 2014 Jun; 42(6):1392-6. PubMed ID: 24561565
[TBL] [Abstract][Full Text] [Related]
20. C1-esterase inhibitor reverses functional consequences of superior mesenteric artery ischemia/reperfusion by limiting reperfusion injury and restoring microcirculatory perfusion.
Lauterbach M; Horstick G; Plum N; Lotz J; Lauterbach E; Weilemann LS; Kempski O
Shock; 2007 Jan; 27(1):75-83. PubMed ID: 17172984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
